Joseph Maakaron, MD^1*, Adam S. Asch, MD², Leslie L. Popplewell, MD, FACP, MPH³, Graham P. Collins, MBBS, MA, MRCP, FRCPath, DPhil⁴, Ian W. Flinn, MD PhD⁵, Nilanjan Ghosh, PhD, MD^6*, Colin Keane^7*, Matthew Ku, MBBS PhD⁸, Amitkumar Mehta, MD⁹, Mark Roschewski, MD¹⁰, Carol O'Hear, MD, PhD^11*, Xuehan Ren^12*, Bertha Villa^12*, Indu Lal^12*, Sonali M. Smith, MD¹³ and Ranjana H. Advani, MD¹⁴

¹University of Minnesota, Minneapolis, MN
²Stephenson Cancer Center Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK
³Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
⁴Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom
⁵Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
⁶Levine Cancer Institute, Atrium Health, Charlotte
⁷Princess Alexandra Hospital, Brisbane, Australia
⁸St Vincent's Hospital, University of Melbourne, Melbourne, Australia
⁹Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
¹⁰Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹¹Gilead Sciences, Foster City, CA
¹²Gilead Sciences Inc, Foster City, CA
¹³Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁴Stanford Cancer Institute, Stanford University, Stanford, CA

Grzegorz S. Nowakowski, MD¹, Johannes Duell, MD^2*, Katerina Kopeckova, MD, PhD^3*, Marek Trneny, MD⁴, Christiane Pott^5*, Mouhamad Khouja, MSc^5*, John M. Burke, MD⁶, Maeve Waldron-Lynch, MD, MRCP^7*, Steve Wagner, PhD^8*, Amitava Mukhopadhyay, PhD^8*, Derek Blair, PhD^8* and David Belada, MUDr, PhD^9*

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Bavaria, Germany
³Department of Oncology of the 2nd Faculty of Medicine of Charles University and University Hospital in Motol, Prague, Czech Republic
⁴Charles University General Hospital, Prague, Czech Republic
⁵Clinic for Internal Medicine II - Haematology, Oncology, University Clinic Schleswig-Holstein, Kiel, Germany
⁶US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO
⁷MorphoSys US, Boston, MA
⁸MorphoSys AG, Planegg, Germany
⁹4th Department of Internal Medicine – Hematology, University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic

Douglas A. Stewart, MD¹, Lois E. Shepherd², Jill J. Dudebout, MD^3*, Jean-François Larouche, MD⁴, Neil Chua, MD^5*, Tara Baetz, MD^6*, Michael Crump⁷, Mona Shafey, MD⁸, Nizar Abdel-Samad, MD⁹, Sue Robinson, MD^10*, Isabelle Fleury, MD¹¹, Deborah Marcellus, MD^12*, Pamela Skrabek, MD, FRCPC¹³, Jesse Kelly^14*, Annette E. Hay¹⁵, Bingshu Chen^16* and John Kuruvilla, MD¹⁷

¹Tom Baker Cancer Centre, Calgary, AB, Canada
²Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada
³Queens University, Kingston, ON, CAN
⁴Hôpital Enfant-Jésus, Centre Hospitalier Universitaire de Quebec, Quebec City, QC, Canada
⁵Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁶Queen's University, Kingston, ON, Canada
⁷Princess Margaret Hospital, Toronto, ON, Canada
⁸Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
⁹The Moncton Hospital, Moncton, NB, Canada
¹⁰Queen Elizabeth II Health Science Center, Halifax, NS, Canada
¹¹Maisonneuve-Rosemont Hospital, Institute of Hematology, Oncology and Cell Therapy, Montreal University, Montreal, QC, Canada
¹²Hamilton Regional Cancer Center, Hamilton, ON, CAN
¹³Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
¹⁴Canadian Cancer Trials Group, Kingston, ON, Canada
¹⁵Canadian Cancer Trials Group, Cancer Research Institute, Kingston, ON, Canada
¹⁶Queen's University, Kingston, ON, CAN
¹⁷University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada

Gao Yan, PhD¹, Xiaoxiao Wang, MD^2*, Bing Bai^1*, Xue-Ping Li^3*, Suxia Lin^4*, Yanxia He^1*, Liqin Ping^1*, Cheng Huang^1*, Jibin Li^5*, Jiaying Mao^1* and Huiqiang Huang, MD, PhD¹

¹Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
²Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
³lixp1@sysucc.org.cn, Guangzhou, China
⁴Sun Yat-sen University Cancer Center, Guangzhou, China
⁵Department of Clinical Research, Sun Yat-sen University Cancer Center, Guanzhou, China

Jia Song^1*, Hui Liu^2*, Zongjiu Jiao^3*, Da Gao^4*, Kai Ding^1*, Yihao Wang^1*, Hong Yu^5*, Yuanyuan Shao^1*, Huijuan Jiang^1*, Shan Gao^1*, Lijuan Li^1*, Rong Fu^2* and Zonghong Shao¹

¹Department of Hematology, General Hospital of Tianjin Medical University, Tianjin, China
²Department of hematology, Tianjin Medical University General Hospital, Tianjin, China
³Department of Hematology, Xingtai People's Hospital, Xingtai, China
⁴Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
⁵Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China

Chelsea C. Pinnix, MD, PhD¹, Bouthaina S. Dabaja, MD^1*, Jillian R. Gunther, MD, PhD^1*, Penny Fang, MD^1*, Susan Wu, MD^1*, Sairah Ahmed, MD², Raphael E Steiner, MD³, Ranjit Nair, MD⁴, Paolo Strati, MD⁵, Jason Westin, MD⁶, Luis Fayad, MD⁵, Swami P. Iyer, MD⁷, Maria Alma Rodriguez, MD^8*, Hun Ju Lee, MD⁵, Felipe Samaniego, MD⁵, Dai Chihara, MD⁵, Preetesh Jain, MBBS, MD, DM, PhD⁹, Lei Feng, MS^10*, Christopher R. Flowers, MD³, Sattva S. Neelapu, MD¹¹ and Loretta J. Nastoupil, MD³

¹Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷UT MDANDERSON, Houston, TX
⁸MD Anderson Cancer Center, Houston, TX
⁹Department of Lymphoma and Myeloma, UTMDACC, Houston, TX
¹⁰Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

Ji Ma, MD^1*, Qiang He^1*, Ke Lu^1* and Liang Wang, MD^2*

¹Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China
²Department of Hematology, Shengli Oilfield Central Hospital, Dongying, AL, China

Moshe Levy, MD^1*, Carl Gustafson, PhD^2*, James Purcell, PhD^2*, Kevin J. Freise, PhD, MS², Wissam Assaily, PhD^3*, Deanna Brackman, PhD^2*, William R. Henner, MS^2*, Michael McDevitt, MD, PhD² and John Kuruvilla, MD⁴

¹Baylor University Medical Center, Dallas, TX
²AbbVie Inc., North Chicago, IL
³AbbVie Inc., North Chicago
⁴Princess Margaret Cancer Centre, Toronto, ON, Canada

Jiefei Bai, MD^1*, Jiangtao Li^1*, Ru Feng, MD^1*, Long Qian^1*, Jingjing Yin^1*, Shuai Zhang^2*, Ting Wang^1*, Yazi Yang^1*, Chunli Zhang^1*, Jian Li, MD³ and Hui Liu, MD^1*

¹Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing, China
²Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing, AL, China
³Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Huilai Zhang^1*, Keshu Zhou^2*, Ying Cheng^3*, Liling Zhang^4*, Haiyan Yang^5*, Liqun Zou, MD, PhD^6*, Junning Cao, MD⁷, Huiqiang Huang⁸, Ye Guo^9*, Zhao Wang¹⁰, Sha Huang^11*, Zhiyu Liang^11*, Hui Yao^11*, Haiyi Guo^11*, Yiqian Fang^11* and Hongjie Zhu^11*

¹Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
²Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
³Jilin Cancer Hospital, Changchun, China
⁴Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
⁶West China Hospital, Sichuan University, Chengdu, China
⁷Fudan University Shanghai Cancer Center, Shanghai, China
⁸Sun Yat-sen University Cancer Center, Guangzhou, China
⁹Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
¹⁰Beijing Friendship Hospital, Capital Medical University, Beijing, China
¹¹BeiGene (Shanghai) Co., Ltd., Shanghai, China

Elizabeth L. Budde, MD, PhD¹, Nancy L. Bartlett^2*, Pratyush Giri^3*, Stephen J. Schuster^4*, Sarit Assouline⁵, Sung-Soo Yoon, MD, PhD⁶, Keith Fay^7*, Matthew J. Matasar, MD, MS⁸, Norma C. Gutierrez^9*, Paula Marlton, MD¹⁰, Martin Dreyling, MD¹¹, Dok Hyun Yoon^12*, Georg Hess, MD^13*, John Radford, MD, FRCPath, FMedSci^14*, Volker Wiebking¹⁵, Shen Yin¹⁵, Eva Cybulski^15*, David C. Turner^15*, Huang Huang^16*, Mingzhu Zhou^17*, Elicia Penuel^15*, Michael C. Wei^15* and Laurie H. Sehn, MD, MPH¹⁸

¹Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
³Royal Adelaide Hospital, Adelaide, Australia
⁴Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Jewish General Hospital, McGill University, Montreal, QC, Canada
⁶Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁷St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
⁸Memorial Sloan Kettering Cancer Center, New York, NY
⁹Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain
¹⁰Princess Alexandra Hospital and University of Queensland, Brisbane, Australia
¹¹Ludwig-Maximilians-University Hospital Munich, Munich, Germany
¹²Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
¹³University Cancer Center Mainz, University Medical School of the Johannes Gutenberg-University, Mainz, Germany
¹⁴Christie NHS Foundation Trust, Manchester, United Kingdom
¹⁵Genentech, Inc., South San Francisco, CA
¹⁶F. Hoffmann-La Roche Ltd., Mississauga, ON, Canada
¹⁷F. Hoffmann-La Roche, Shanghai, China
¹⁸BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada

Jianai Sun^1,2*, Yi Xu^2*, Min Yang, M.D.^1,3*, Huafeng Wang^1,2*, Wenjuan Yu, MD^3*, Liangshun You^1,2*, Haitao Meng^1,2*, Chunmei Yang^1,3*, Xinping Zhou^1,2*, Li Li^1,2*, De Zhou, MD^1,2*, Xiujing Ye^1,2*, Hong-hu Zhu, M.D., Ph.D.^1,2*, Hongyan Tong^1,2*, Jie Jin, M.D., Ph.D.^1,2 and Wanzhuo Xie^1,3*

¹Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, Zhejiang, PR China, Hangzhou, China
²Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China, Hangzhou, China
³Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Adam J. Olszewski^1*, Elizabeth L. Budde, MD, PhD², Julio Chavez³, Nilanjan Ghosh, PhD, MD^4*, Manali Kamdar^5*, Izidore S. Lossos, MD³, Catherine Diefenbach^6*, Waleed Sabry^7*, Kathleen Dorritie⁸, Ling-Yuh Huw^9*, Song Pham^10*, Ting Jia^10*, Hao Wu^9*, Iris To^9*, Michael C. Wei⁹ and Sarit Assouline¹¹

¹Brown University, Providence, RI
²Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³University of Miami, Miami, FL
⁴Atrium Health Levine Cancer Institute, Charlotte, NC
⁵University of Colorado Cancer Center, Aurora, CO
⁶Perlmutter Cancer Center at NYU Langone Health, New York, NY
⁷Saskatoon Cancer Center, Saskatoon, SK, Canada
⁸UPMC Hillman Cancer Center, Pittsburgh, PA
⁹Genentech, Inc., South San Francisco, CA
¹⁰F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹¹Jewish General Hospital, McGill University, Montreal, QC, Canada

Martine Bagot^1*, Youn H. Kim, MD², Pablo L. Ortiz-Romero^3*, Pier Luigi Zinzani, MD, PhD⁴, Neha Mehta-Shah, MD, MSCI⁵, Olivier Dereure^6*, Marie Beylot-Barry^7*, Stéphane Dalle^8*, Eric D Jacobsen⁹, Auris Huen, MD, PharmD^10*, Andrea Combalia^11*, Maxime Battistella, MD, PhD^12*, Alejandro A. Gru, MD^13*, Hélène Moins-Teisserenc, MD, PhD^14*, Michael S. Khodadoust, MD PhD¹⁵, Julien Viotti^16*, Christine Paiva^16*, Marianna Muller^16* and Pierluigi Porcu, MD¹⁷

¹Department of Dermatology, Hôpital Saint Louis, Université Paris Cité, Inserm U976, Paris, CT, France
²Stanford Cancer Institute, Stanford, CA
³Department of Dermatology, Hospital 12 de Octubre Medical School, University Complutense, Madrid, Spain
⁴Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy
⁵Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁶Department of Dermatology, CHU Montpellier, Université Montpellier I, Montpellier, France
⁷Department of Dermatology, Centre Hospitalier Universitaire de Bordeaux – Hôpital Saint-André, B, Bordeaux, France
⁸Department of Dermatology, Hospices Civils de Lyon, Pierre Bénite, Lyon, France
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Dermatology, Hospital Clinic de Barcelona, Barcelona, Spain
¹²INSERM U1165, Universite Paris 7, AP-HP Hopital Saint Louis, Paris, FRA
¹³Department of Pathology, University of Virginia, Charlottesville, VA
¹⁴Hematology Laboratory, Hopital Saint-Louis, AP-HP, Université Paris Cité, INSERM U976, Paris, France
¹⁵Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
¹⁶INNATE PHARMA, Marseille, France
¹⁷Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, PA

Hui-Qiang Huang, MD PhD¹, Gao Yan, PhD², Ming Jiang^3*, Lihong Liu^4*, Qing Xiao^5*, Yufu Li, MD^6*, Hui Zhou^7*, Jianfei Xue^8*, Dong Wang^9*, Dapeng Xie^10*, Honglian Li^11* and Peng Wang^10*

¹Sun Yat-sen University Cancer Center, Guangzhou, China
²Department of Medical Oncology, Sun Yat-Sen University Cancer Center, GuangZhou, China
³West China Hospital of Sichuan University, Sichuan, China
⁴Department of Hematology, The Fourth Hospital of Hebei Medical University, Hebei, China
⁵The first affilicated hospital of Chongqing medical unversity, Chongqing, China
⁶Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁷Department of Lymphoma & Hematology, Hunan Cancer Hospital/The Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, China
⁸CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Shijiazhuang, China
⁹CSPC Zhongqi pharmaceutical technology (Shijiazhuang) Ltd, Guangzhou, China
¹⁰CSPC Zhongqi pharmaceutical technology (Shijiazhuang) Ltd, Shanghai, China
¹¹lihonglian@cspc.cn, Shijiazhuang, Chile

Siyu Fan^1*, Chong Jiang^2*, Yue Teng^2*, Ang Li^3*, Jianxin Chen^3* and Jingyan Xu, MD⁴

¹China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China
²Department of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
³The Key Laboratory of Broadband Wireless Communication and Sensor Network Technology (Ministry of Education), Nanjing, China
⁴Department of Hematology, Nanjing Drum Tower Hospital, Nanjing, China

Neil Bailey, MSc^1*, Tori Braun, BS^1*, Megumi Bailey, MSc^2*, Tenzin Tsomo, BS^1*, Jennie Szeto, BS^1*, Sandra Benitez Kruidenier, PA-C^1*, Vanessa Dunleavy, ARNP^1*, Joanna Fesler, ARNP^1*, Gayle Funk, PA-C^1*, Sonia Glennie, ARNP^1*, Judson Hall, PA-C^1*, Julia Parker, ARNP^1*, Daniel Egan, MD^1*, Raya Mawad, MD^3*, Carol A Dean, MPH, BSN, RN, OCN^1*, Suzan Sullivan, BSN, RN^1*, Chia Lu, MS, RN, OCN, BMTCN^1*, Heidi Hohmann, RN, BSN, OCN^1*, Jordan Briggs, RN, BSN, OCN^1* and Krish Patel, MD⁴

¹Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA
²Center for Blood Disorders and Stem Cellular Therapy, Swedish Cancer Institute, Seattle, WA
³Swedish Center for Blood Disorders and Cellular Therapy, Seattle, WA
⁴Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle

Zhihua Yao^1*, Zheng Yan^2*, Shuna Yao^3*, Haiying Wang^3*, Junfeng Chu^3*, Shuang Zhao^3*, Jie Ma^3*, Bing Wei^3*, Jiawen Zheng^3*, Quande Lin, PhD^4,5*, Zheng Xu^6*, Xinyang Zhao, PhD⁷ and Yanyan Liu^8*

¹Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, ZhengZhou, China
²Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
³Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
⁴Henan Cancer Hospital, Zhengzhou, China
⁵Henan cancer hospital, Affiliated cancer hospital of Zhengzhou University., Zhengzhou, China
⁶Xinyang Central Hospital, Xinyang, China
⁷Department of Biochemistry and Molecular Genetics, University of Alabama At Birmingham, Birmingham, AL
⁸Affiliated Cancer Hospital of Zhengzhou University, zhengzhou, China

Miao Qing, MD^1*, Yongfen Huang^1*, Can Chen^2*, Lingling Wang^1*, Jun Feng^1*, Chuanhai Xu^1*, Yuexin Cheng^1*, Jianming Dong^1*, Linlin Zhang^1* and Hao Xu^1*

¹Yancheng First People's Hospital, Yancheng, China
²Xuzhou Medical University, Yancheng, China

Jason Westin, MD¹, Adam J. Olszewski^2*, Laura Maria Fogliatto³, Won-Seog Kim^4*, Ho-Jin Shin^5*, Hao Wu^6*, Shen Yin⁶, Song Pham^7*, Elicia Penuel^6*, Jing Jing^6*, Michael C. Wei^6* and Elizabeth L. Budde, MD, PhD⁸

¹MD Anderson Cancer Center, Houston, TX
²Brown University, Providence, RI
³Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
⁴Samsung Medical Center, Seoul, Korea, Republic of (South)
⁵Pusan National University Hospital, Busan, Korea, Republic of (South)
⁶Genentech, Inc., South San Francisco, CA
⁷F. Hoffman-La Roche Ltd., Mississauga, ON, Canada
⁸Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA